Important role of nondiagnostic blood loss and blunted erythropoietic response in the anemia of medical intensive care patients

Critical Care Medicine

Volumn 27, Issue 12, 1999, Pages 2630-2639

  Von Ahsen, Nicolas ^a,b   Müller, Christian ^a   Serke, Stefan ^a   Frei, Ulrich ^a   Eckardt, Kai Uwe ^a  

^a HUMBOLDT UNIVERSITY   (Germany)

^b UNIVERSITY OF GÖTTINGEN   (Germany)

Author keywords

Anemia; Blood loss; Critical care; Erythropoietin; Hemoglobin; Hemolysis; Iatrogenic; Intensive care; Iron; Red blood cell transfusion; Reticulocytes; Transfusion prediction

Indexed keywords

CYANOCOBALAMIN; ERYTHROPOIETIN; FERRITIN; FOLIC ACID; HAPTOGLOBIN; HEMOGLOBIN; IRON; TRANSFERRIN;

ACUTE KIDNEY FAILURE; ADULT; AGED; ANEMIA; ARTICLE; BLEEDING; CONTROLLED STUDY; DISEASE COURSE; DISEASE SEVERITY; ERYTHROCYTE METABOLISM; ERYTHROCYTE TRANSFUSION; ERYTHROPOIESIS; FEMALE; HEMOGLOBIN DETERMINATION; HUMAN; INTENSIVE CARE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RETICULOCYTE COUNT; SEROLOGY; TRANSFERRIN BLOOD LEVEL; TREATMENT INDICATION; TREATMENT OUTCOME;

EID: 0033397526     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003246-199912000-00005     Document Type: Article

References (53)

1. 1. Hebert PC, Wells G, Tweeddale M, et al: Does transfusion practice affect mortality in critically ill patients? Transfusion Requirements in Critical Care (TRICC) Investigators and the Canadian Critical Care Trials Group. Am J Respir Crit Care Med 1997; 155: 1618-1623
2. 2. Corwin HL, Parsonnet KC, Gettinger A: RBC transfusion in the ICU: Is there a reason? Chest 1995; 108:767-771
3. 3. Johnson RG, Thurer RL, Kruskall MS, et al: Comparison of two transfusion strategies after elective operations for myocardial revascularization. J Thorac Cardiovasc Surg 1992; 104:307-314
4. 4. Weisel RD, Charlesworth DC, Mickleborough LL, et al: Limitations of blood conservation. J Thorac Cardiovasc Surg 1984; 88:26-38
5. 5. Carson JL, Duff A, Poses RM, et al: Effect of anaemia and cardiovascular disease on surgical mortality and morbidity. Lancet 1996; 348:1055-1060
6. 6. Crosby ET: Perioperative haemotherapy: II. Risks and complications of blood transfusion. Can J Anaesth 1992; 39:822-837
7. 7. Jayabose S, Tugal O, Ruddy R, et al: Transfusion therapy for severe anemia. Long-term survival after blood transfusion. Transfusion 1994; 34:471-477
8. 8. Jensen LS, Kissmeyer Nielsen P, Wolff B, et al: Randomised comparison of leucocyte-depleted versus buffy-coat-poor blood transfusion and complications after colorectal surgery. Lancet 1996; 348:841-845
9. 9. Bordin JO, Heddle NM, Blajchman MA: Biologic effects of leukocytes present in transfused cellular blood products. Blood 1994; 84:1703-1721
10. 10. Blumberg N, Heal JM: Immunomodulation by blood transfusion: An evolving scientific and clinical challenge. Am J Med 1996; 101: 299-308
11. 11. Nielsen HJ: Detrimental effects of perioperative blood transfusion. Br J Sury 1995; 82: 582-587
12. 12. Chernow B, Jackson E, Miller JA, et al: Blood conservation in acute care and critical care. AACN Clin Issues 1996; 7:191-197
13. 13. Dale JC, Pruett SK: Phlebotomy: A minimalist approach. Mayo Clin Proc 1993; 68: 249-255
14. 14. Smoller BR, Kruskall MS, Horowitz GL: Reducing adult phlebotomy blood loss with the use of pediatric-sized blood collection tubes. Am J Clin Pathol 1989; 91:701-703
15. 15. Silver MJ, Li YH, Gragg LA, et al: Reduction of blood loss from diagnostic sampling in critically ill patients using a blood-conserving arterial line system. Chest 1993; 104: 1711-1715
16. 16. Spence RK: Perfluorocarbons in the twenty-first century: Clinical applications as transfusion alternatives. Artif Cells Blood Substit Immobil Biotechnol 1995; 23:367-380
17. 17. Hess JR: Blood substitutes. Semin Hematol 1996; 33:369-378
18. 18. Goodnough LT, Monk TG, Andriole GL: Erythropoietin therapy. N Engl J Med 1997; 336:933-938
19. 19. Smoller BR, Kruskall MS: Phlebotomy for diagnostic laboratory tests in adults: Pattern of use and effect on transfusion requirements. N Enal J Med 1986; 314:1233-1235
20. 20. Tarpey J, Lawler PG: latrogenic anaemia? A survey of venesection in patients in the intensive therapy unit. Anaesthesia 1990; 45: 396-398
21. 21. Alazia M, Colavolpe JC, Botti G, et al: Spoliations sanguines liees aux prelevements en reanimation: Etude preliminaire. Ann Fr Anesth Reanim 1996; 15:1004-1007
22. 22. Krafte Jacobs B, Levetown ML, Bray GL, et al: Erythropoietin response to critical illness. Crit Care Med 1994; 22:821-826
23. 23. Rogiers P, Zhang H, Leeman M, et al: Erythropoietin response is blunted in critically ill patients. Intensive Care Med 1997; 23: 159-162
24. 24. Jelkmann W: Erythropoietin: Structure, control of production, and function. Physiol Rev 1992; 72:449-489
25. 25. Eckardt KU, Kurtz A, Hirth P, et al: Evaluation of the stability of human erythropoietin in samples for radioimmunoassay. Klin Wochenschr 1988; 66:241-245
26. 26. Villamor N, Kirsch A, Huhn D, et al: Interference of blood leucocytes in the measurements of immature red cells (reticulocytes) by two different (semi-) automated flowcytometry technologies. Clin Lab Haematol 1996; 18:89-94
27. 27. Salama A, Mueller-Eckhardt C, Schmitt H: Erythrozytenkonzentrate. In: Leitlinien zur Therapie mit Blutkomponenten und Plasmaderivaten. Vorstand und Wissenschaftlicher Beirat der Bundesärztekammer (Eds.). Köln, Deutscher Ärzte Verlag, 1995. pp 9-27
28. 28. Le Gall JR, Lemeshow S, Saulnier F: A new simplified acute physiology score (SAPS II) based on a European/North American multicenter study. JAMA 1993; 270:2957-2963
29. 29. Baumann H, Gauldie J: The acute phase response. Immunol Today 1994; 15:74-80
30. 30. Eckardt KU, Hartmann W, Vetter U, et al: Serum immunoreactive erythropoietin of children in health and disease. Eur J Pediatr 1990; 149:459-464
31. 31. Rege AB, Brookins J, Fisher JW: A radioimmunoassay for erythropoietin: Serum levels in normal human subjects and patients with hemopoietic disorders. J Lab Clin Med 1982; 100:829-843
32. 32. Erslev AJ, Wilson J, Caro J: Erythropoietin titers in anemic, nonuremic patients. J Lab Clin Med 1987; 109:429-433
33. 33. Zimmerman JE, Seneff MG, Sun X, et al: Evaluating laboratory usage in the intensive care unit: Patient and institutional characteristics that influence frequency of blood sampling. Crit Care Med 1997; 25:737-748
34. 34. Hadfield RJ, Sinclair DC, Houldsworth PE, et al: Effects of enteral and parenteral nutrition on gut mucosal permeability in the critically ill. Am J Respir Crit Care Med 1995; 152: 1545-1548
35. 35. Kudsk KA: Clinical applications of enteral nutrition. Nutr Clin Pract 1994; 9:165-171
36. 36. Jongen Lavrencic M, Peeters HR, Rozemuller H, et al: IL-6-induced anaemia in rats: Possible pathogenetic implications for anemia observed in chronic inflammations. Clin Exp Immunol 1996; 103:328-334
37. 37. Means-RT J, Krantz SB: Progress in understanding the pathogenesis of the anemia of chronic disease. Blood 1992; 80:1639-1647
38. 38. Danielson B: R-HuEPO hyporesponsiveness: Who and why? Nephrol Dial Transplant 1995; 10(Suppl 2):69-73
39. 39. Biesma DH, Van de Wiel A, Beguin Y, et al: Post-operative erythropoiesis is limited by the inflammatory effect of surgery on iron metabolism. Eur J Clin Invest 1995; 25: 383-389
40. 40. Bainton DF, Finch CA: The diagnosis of iron deficiency anemia. Am J Med 1964; 37:62-70
41. 41. National Kidney Foundation - DOQI Clinical Practice Guidelines for the Treatment of Anemia of Chronic Renal Failure. New York, NY, National Kidney Foundation, 1997. pp 30-46
42. 42. Baer AN, Dessypris EN, Goldwasser E, et al: Blunted erythropoietin response to anaemia in rheumatoid arthritis. Br J Haematol 1987; 66:559-564
43. 43. Erslev AJ, Besarab A: Erythropoietin in the pathogenesis and treatment of the anemia of chronic renal failure. Kidney Int 1997; 51: 622-630
44. 44. Abel J, Spannbrucker N, Fandrey J, et al: Serum erythropoietin levels in patients with sepsis and septic shock. Eur J Haematol 1996; 57:359-363
45. 45. Faquin WC, Schneider TJ, Goldberg MA: Effeet of inflammatory cytokines on hypoxia-induced erythropoietin production. Blood 1992; 79:1987-1994
46. 46. Nielsen OJ, Thaysen JH: Erythropoietin deficiency in acute tubular necrosis. J Intern Med 1990; 227:373-380
47. 47. Lipkin GW, Kendall RG, Russon LJ, et al: Erythropoietin deficiency in acute renal failure. Nephrol Dial Transplant 1990; 5: 920-922
48. 48. Expert Working Group: Guidelines for red blood cell and plasma transfusion for adults and children. Can Med Assoc J 1997; 156(Suppl 11):S1-S24
49. 49. American College of Physicians: Practice strategies for elective red blood cell transfusion. Ann Intern Med 1992; 116:403-406
50. 50. Consensus conference: Perioperative red blood cell transfusion. JAMA 1988; 260: 2700-2703
51. 51. Blair SD, Janvrin SB, McCollum CN, et al: Effect of early blood transfusion on gastrointestinal haemorrhage. Br J Surg 1986; 73: 783-785
52. 52. Hebert PC, Wells G, Marshall J, et al: Transfusion requirements in critical care: A pilot study. Canadian Critical Care Trials Group. JAMA 1995; 273:1439-1444
53. 53. Vichinsky EP, Haberkern CM, Neumayr L, et al: A comparison of conservative and aggressive transfusion regimens in the perioperative management of sickle cell disease: The Preoperative Transfusion in Sickle Cell Disease Study Group. N Engl J Med 1995; 333: 206-213